Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study.

Simon VulfsonsMiriam OgnitzBar-Sela GilAyelet Raz-PasteurElon Eisenberg

Published in: Palliative & supportive care (2020)

Cannabis inhalation by combustion is not feasible for hospitalized patients. The use of Syqe Inhaler during hospitalization yielded high levels of patients and staff satisfaction with no complications.

Keyphrases

open label
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
clinical trial
study protocol
prognostic factors
risk factors
particulate matter
patient reported outcomes
risk assessment
phase ii study
long term care